Patel KK,Qavi AJ,Hock KG,Gronowski AM .2016 .Establishing reference intervals for HCG in postmenopausal women. Clin Biochem, 11(4-5) : 234-7.
Jones GR,Koetsier S. .2017 .Uptake of recommended common reference intervals for chemical pathology in Australia. , 54(3) : 395-7.
Sturgeon CM,Sprague S,Almond A,Cavalier E,Fraser WD,Algeciras-Schimnich A .2016 .Perspective and priorities for improvement of parathyroid hormone (PTH) measurement-A view from the IFCC Working Group for PTH. Clin Chim Acta, 10(5) : 42-7.
Ichihara K. .2014 .Statistical considerations for harmonization of the global multicenter study on reference values. Clin Chim Acta, 01(3) : 108-18.
Ichihara K,Ozarda Y,Barth JH,Klee G,Shimizu Y,Xia L .2016 .A global multicenter study on reference values: 2. Exploration of sources of variation across the countries. Clin Chim Acta, 09(6) : 83-97.
Horowitz GL,Altaie S,Boyd JC .2010 .Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. , 28 : 3-A3.
Ozarda Y,Ichihara K,Barth JH,Klee G .2013 .Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. -0249, 51(5) : 1027-40.
Stewart BW,Wild CP .2014 .. fr/Non-Series-Publications/ World-Cancer-Reports/World-Cancer-Report-2014, : .
Munaf A,Memon MS,Kumar P,Ahmed S,Kumar MB .2014 .Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV-cohort from liver clinics in Pakistan. APJCP, 15(18) : 7563-7.
Butt AS,Hamid S,Wadalawala AA,Ghufran M,Javed AA,Farooq O,Ahmed B .2013 .Hepatocellular carcinoma in native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viralhepatocellular carcinoma. BMC Res, 6(1) : 1756-3.
.2005 .Diagnosis of hepatocellular carcinoma. HPB (Oxford), 7(1) : 26-34.
Liebman HA,Furie BC,Tong MJ,Blanchard RA,Lo KJ,Lee SD .1984 .Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. NEJM, 31(22) : 1427-31.
Cui SX,Yu XF,Qu XJ .2016 .Roles and signaling pathways of des-γ- carboxyprothrombin in the progression of hepatocellular carcinoma. Can Invest, 20(9) : 459-64.
Yu R,Xiang X,Tan Z,Zhou Y,Wang H,Deng G .2016 .Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients. Sci Rep, 6(9) : 35050.
Saitta C,Raffa G,Alibrandi A,Brancatelli S,Lombardo D,Tripodi G .2017 .PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients. Medicine, 96(26) : .
Horn PS,Pesce AJ .2003 .Reference intervals: an update. Clin Chim Acta, 8981(03) : 00133-5.
Fujita K,Kinukawa H,Ohno K,Ito Y,Saegusa H,Yoshimura T .2015 .Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II. Clin Biochem, 07(18) : 1330-6.
Gandham G,Jayamohanan H,Ponnada B,Kumar A,Keechilat P .2020 .Correlation of serum PIVKA-II and AFP level with portal vein tumor thrombus and BCLC stage in newly diagnosed hepatocellular carcinoma patients. J Clin Oncol, 38(suppl) : .
Kim MJ,Bae KW,Seo PJ,Jeong IK,Kim JH,Lee BH .2006 .Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve. Korean J Gastroenterol, 12(3) : 404-11.
Viggiani V,Palombi S,Gennarini G,D'Ettorre G,De Vito C,Angeloni A .2016 .Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients. Scand J Gastroenterol, 51(10) : 1257-62.